Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
4.950
-0.200 (-3.88%)
Mar 31, 2025, 3:13 PM EDT - Market open
Cara Therapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Hold
Price Target
$12.00
Upside
+142.42%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $120 → $12 | Strong Buy → Hold | Downgrades | $120 → $12 | +142.42% | Jun 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 13, 2024 |
| Needham | Needham | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jun 13, 2024 |
| Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,112.12% | May 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $43 | Strong Buy | Reiterates | $43 | +772.73% | May 15, 2024 |
| Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,112.12% | May 14, 2024 |
| Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,112.12% | Apr 10, 2024 |
| Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,112.12% | Mar 28, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $132 → $120 | Strong Buy | Maintains | $132 → $120 | +2,324.24% | Mar 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +1,112.12% | Mar 5, 2024 |
| Needham | Needham | Strong Buy Maintains $72 → $60 | Strong Buy | Maintains | $72 → $60 | +1,112.12% | Jan 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $84 → $30 | Strong Buy | Maintains | $84 → $30 | +506.06% | Dec 19, 2023 |
| Needham | Needham | Strong Buy Maintains $264 → $72 | Strong Buy | Maintains | $264 → $72 | +1,354.55% | Dec 18, 2023 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $144 → $12 | Buy → Hold | Downgrades | $144 → $12 | +142.42% | Nov 14, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $180 → $84 | Strong Buy | Maintains | $180 → $84 | +1,596.97% | Oct 19, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $156 → $144 | Buy | Maintains | $156 → $144 | +2,809.09% | Aug 8, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.